Five Prime Therapeutics, Inc. Operating Lease, Liability, Current
Five Prime Therapeutics, Inc. had Operating Lease, Liability, Current of $5.13 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2021-03-22
- 2020-12-31: Operating Lease, Liability, Current $5.13M.
- 2020-09-30: Operating Lease, Liability, Current $4.20M.
- 2020-06-30: Operating Lease, Liability, Current $4.40M.
- 2020-03-31: Operating Lease, Liability, Current $4.22M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2020-12-31 | $5.13M 10-K · filed 2021-03-22 |
| 2020-09-30 | $4.20M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $4.40M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.22M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.08M 10-K · filed 2021-03-22 |
| 2019-09-30 | $3.94M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.83M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.70M 10-Q · filed 2019-05-09 |